Literature DB >> 25237190

Gln-362 of angiopoietin-2 mediates migration of tumor and endothelial cells through association with α5β1 integrin.

Hyo Seon Lee1, Seung Ja Oh1, Kwang-Hoon Lee1, Yoon-Sook Lee1, Eun Ko1, Kyung Eun Kim1, Hyung-chan Kim1, Seokkyun Kim1, Paul H Song1, Yong-In Kim2, Chungho Kim3, Sangyeul Han4.   

Abstract

Angiopoietin-2 (Ang-2) not only regulates angiogenesis by binding to its well known receptor Tie2 on endothelial cells but also controls sprouting of Tie2-negative angiogenic endothelial cells and invasion of Tie2-negative non-endothelial cells by binding to integrins. However, the molecular mechanism of the Ang-2/integrin association has been unclear. In this study, we found that the Gln-362 residue of Ang-2 was essential for binding to α5β1 integrin. A Q362E Ang-2 mutant, which still bound to Tie2, failed to associate with α5β1 integrin and was unable to activate the integrin downstream signaling of focal adhesion kinase. In addition, unlike wild-type Ang-2, the Q362E Ang-2 mutant was defective in mediating invasion of Tie2-negative glioma or Tie2-positive endothelial cells. Furthermore, the tailpiece domain of the α5 subunit in α5β1 integrin was critical for binding to Ang-2. Taken together, these results provide a novel insight into the mechanism of integrin regulation by Ang-2, which contributes to tumor invasion and endothelial cell migration in a Tie2-independent manner.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Angiogenesis; Angiopoietin-2; Cell Invasion; Cell Migration; Endothelial Cell; Integrin; Tie2

Mesh:

Substances:

Year:  2014        PMID: 25237190      PMCID: PMC4223333          DOI: 10.1074/jbc.M114.572594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.

Authors:  William A Barton; Dorothea Tzvetkova-Robev; Edward P Miranda; Momchil V Kolev; Kanagalaghatta R Rajashankar; Juha P Himanen; Dimitar B Nikolov
Journal:  Nat Struct Mol Biol       Date:  2006-05-28       Impact factor: 15.369

2.  Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival.

Authors:  Christian Sfiligoi; Annarita de Luca; Ilaria Cascone; Valentina Sorbello; Luca Fuso; Riccardo Ponzone; Nicoletta Biglia; Enrica Audero; Riccardo Arisio; Federico Bussolino; Piero Sismondi; Michele De Bortoli
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

3.  Multiple effects of angiopoietin-2 blockade on tumors.

Authors:  Claire E Lewis; Napoleone Ferrara
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.

Authors:  Christopher Daly; Alexandra Eichten; Carla Castanaro; Elizabeth Pasnikowski; Alexander Adler; Alshad S Lalani; Nicholas Papadopoulos; Alastair H Kyle; Andrew I Minchinton; George D Yancopoulos; Gavin Thurston
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

5.  MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.

Authors:  Ching Ching Leow; Karen Coffman; Ivan Inigo; Shannon Breen; Meggan Czapiga; Serguei Soukharev; Neill Gingles; Norman Peterson; Christine Fazenbaker; Rob Woods; Bahija Jallal; Sally-Ann Ricketts; Theresa Lavallee; Steve Coats; Yong Chang
Journal:  Int J Oncol       Date:  2012-02-10       Impact factor: 5.650

6.  Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.

Authors:  Bo Hu; Ping Guo; Quan Fang; Huo-Quan Tao; Degui Wang; Motoo Nagane; Hui-Jein Su Huang; Yuji Gunji; Ryo Nishikawa; Kari Alitalo; Webster K Cavenee; Shi-Yuan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

Review 7.  Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.

Authors:  Damien Gerald; Sudhakar Chintharlapalli; Hellmut G Augustin; Laura E Benjamin
Journal:  Cancer Res       Date:  2013-03-06       Impact factor: 12.701

8.  Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.

Authors:  Moritz Felcht; Robert Luck; Alexander Schering; Philipp Seidel; Kshitij Srivastava; Junhao Hu; Arne Bartol; Yvonne Kienast; Christiane Vettel; Elias K Loos; Simone Kutschera; Susanne Bartels; Sila Appak; Eva Besemfelder; Dorothee Terhardt; Emmanouil Chavakis; Thomas Wieland; Christian Klein; Markus Thomas; Akiyoshi Uemura; Sergij Goerdt; Hellmut G Augustin
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

9.  A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.

Authors:  Hak-Zoo Kim; Keehoon Jung; Ho Min Kim; Yifan Cheng; Gou Young Koh
Journal:  Biochim Biophys Acta       Date:  2009-02-10

10.  Complete integrin headpiece opening in eight steps.

Authors:  Jieqing Zhu; Jianghai Zhu; Timothy A Springer
Journal:  J Cell Biol       Date:  2013-06-24       Impact factor: 10.539

View more
  11 in total

Review 1.  Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.

Authors:  Lorena Zuliani-Alvarez; Kim S Midwood
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-05-01       Impact factor: 4.730

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 3.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

4.  The role of angiopoietin-2 in nucleus pulposus cells during human intervertebral disc degeneration.

Authors:  Kun Wang; Wei Liu; Yu Song; Xinghuo Wu; Yukun Zhang; Shuai Li; Yong Gao; Ji Tu; Yingle Liu; Cao Yang
Journal:  Lab Invest       Date:  2017-04-10       Impact factor: 5.662

Review 5.  Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.

Authors:  Racheal G Akwii; Md S Sajib; Fatema T Zahra; Constantinos M Mikelis
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

Review 6.  Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential.

Authors:  Michael Whitehead; Andrew Osborne; Peter S Widdowson; Patrick Yu-Wai-Man; Keith R Martin
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

7.  Endothelium-specific deletion of Nox4 delays retinal vascular development and mitigates pathological angiogenesis.

Authors:  Xixiang Tang; Joshua J Wang; Jinli Wang; Hanna E Abboud; Yanming Chen; Sarah X Zhang
Journal:  Angiogenesis       Date:  2020-11-17       Impact factor: 9.596

8.  Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin.

Authors:  Annamarie C Dalton; Tomer Shlamkovitch; Niv Papo; William A Barton
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

Review 9.  Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.

Authors:  Lauri Eklund; Jaakko Kangas; Pipsa Saharinen
Journal:  Clin Sci (Lond)       Date:  2017-01-01       Impact factor: 6.124

Review 10.  Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Authors:  Laure Malric; Sylvie Monferran; Julia Gilhodes; Sabrina Boyrie; Perrine Dahan; Nicolas Skuli; Julie Sesen; Thomas Filleron; Aline Kowalski-Chauvel; Elizabeth Cohen-Jonathan Moyal; Christine Toulas; Anthony Lemarié
Journal:  Oncotarget       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.